Research and understanding of lower urinary tract symptoms and associated clinical BPH have evolved tremendously over the past years. Detailed analyses of data from the Olmsted County Study of Urinary Symptoms in Men has taught us that it is not symptom severity and frequency alone that prompt men to consult a physician. Rather, issues such as bother, interference with daily activities, embarrassment about urinary conditions, and worry about the possibility of malignancy all very significantly contribute to the decision to see a physician.
Washington-As negotiations intensify in Washington to develop
a patients' bill of rights that can be passed and signed into law, insurance
industry and business opponents are attempting to convince physicians that
they are in danger of being confronted with a new source of lawsuits themselves
if such legislation is enacted.
New Orleans-Scientists from two Cleveland institutions have identified
a chromosomal region they believe contains a gene or genes associated with
aggressive forms of prostate cancer. Tests for molecular markers of genetic
abnormalities in this region could some day identify men with prostate cancer
who warrant aggressive therapies, as well as spare some men from treatment.
Minneapolis-American Medical Systems has received FDA approval for InhibiZone, an antibiotic surface treatment used on its AMS 700 series penile prostheses. The treatment is impregnated through a patented process into the tissue-contacting surfaces of the prostheses. In laboratory testing, the device elutes the drugs from the surface when exposed to a warm, moist environment, providing antibiotic action both on the surface and in a zone surrounding the treated device, according to the company.
Palm Harbor, FL-Sempermed offers the SemperCARE Nitrile Powder-Free Exam Glove to eliminate the potential for aerosolization of glove powder and associated transfer of chemical allergens. The non-latex glove is ergonomically designed and made from a low modulus synthetic polymer, which maximizes comfort, tactile sensitivity, and protection from blood-borne pathogens, according to the company. Its textured surface provides better gripping, while the light blue color optimizes visibility.
Providing employees with rewards for achieving goals boosts morale and
the bottom line
Q My group practice pays the premium for my medical malpractice insurance
policy. What can I do to protect my assets if I'm either sued beyond the
malpractice maximum or for reasons other than the practice of urology?
The use of intracytoplasmic sperm injection has increased dramatically in the United States since 1995, while the proportion of patients receiving treatment for male-factor infertility has remained stable, according to a study in the New England Journal of Medicine (2007; 357:251-7).
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant using cells harvested from the patient before the initial chemotherapy infusion, suggests a retrospective review by researchers from Indiana University School of Medicine, Indianapolis.
Las Vegas--Urologists are beginning to use a more extensive biopsy
regimen when working up men with suspected prostate cancer. Although this
is paying off in increased disease detection, it also has raised questions
about whether some men are being over-treated for clinically insignificant